EFTA Document EFTA01452434
US Healthca re Propsed Updated Current Total Equity Bristol Myers $ 2.50 $ 2.00 $ 2.00 Pfizer $ 2.50 $ 2.00 $ 2.00 Merck $ 2.50 $ 2.00 $ 2.00 Valeant $ 1.50 $ 1.00 $ 1.00 Actavis $ 1.50 $ 1.00 $ 1.00 Gilead $ 1.50 $ 2.00 $ 2.00 Mylan $ 1.00 $ 1.00 $ 1.00 Endo Health $ 1.00 $ 1.00 $ 1.00 HCA $ 030 $ 1.00 $ 1.00 Rite Aid $ 0.50 $ 0.50 $ 0.50 Ariad $ 0.10 $ 0.10 Biogen $ 0.40 $ 0.W $ 1.00 Sangamo Biosciences
Summary
US Healthca re Propsed Updated Current Total Equity Bristol Myers $ 2.50 $ 2.00 $ 2.00 Pfizer $ 2.50 $ 2.00 $ 2.00 Merck $ 2.50 $ 2.00 $ 2.00 Valeant $ 1.50 $ 1.00 $ 1.00 Actavis $ 1.50 $ 1.00 $ 1.00 Gilead $ 1.50 $ 2.00 $ 2.00 Mylan $ 1.00 $ 1.00 $ 1.00 Endo Health $ 1.00 $ 1.00 $ 1.00 HCA $ 030 $ 1.00 $ 1.00 Rite Aid $ 0.50 $ 0.50 $ 0.50 Ariad $ 0.10 $ 0.10 Biogen $ 0.40 $ 0.W $ 1.00 Sangamo Biosciences
Ask AI About This Document
Extracted Text (OCR)
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.